key: cord-0927968-tt9ttyke authors: Martelletti, Paolo; Bentivegna, E.; Spuntarelli, V.; Luciani, M. title: Long-COVID Headache date: 2021-05-20 journal: SN Compr Clin Med DOI: 10.1007/s42399-021-00964-7 sha: 6c8d17e17d1965331bfa94371a0b9379d2bcb0fc doc_id: 927968 cord_uid: tt9ttyke The so-called long COVID-19 is a set of symptoms that accompanies the patient even for months after discharge from the hospital. These symptoms include easy muscle fatigue, moderate breathlessness, persistent headache, the feeling of a foggy head, and the development of psychiatric disorders. In general, the quality of life of at least half of the patients who come out of the COVID-19 syndrome, both mild and severe, shows a markedly worsening despite having passed a difficult physical and psychological test. Among all the neurological disorders that can most frequently be found in the long COVID-19, it is important to consider the persistent headache symptomatology as a possible chronic sequela of the infection. Since there is not a definition in the International Headache Society classification of this type of headache, we must focus our attention on this long-COVID-19 headache especially because clinical studies are being planned to collect big data for the International Headache Society Classification Committee. Headache occurs as one of the initial symptoms of infection in COVID-19. It can be spread throughout the skull, giving a feeling of constriction and weight at the top of the head. All this occurs in a large part of subjects who present the first symptoms of COVID-19 in a percentage that varies from 14 to 60% [1] [2] [3] . If the infection affects a subject already suffering from migraine, it multiplies the crises and makes recognition not immediate, together with the fever, fatigue, muscle weakness, and respiratory difficulty of the infection [1] . The symptomatology of COVID-19 infection is multifaceted and depends on the involvement of multiple systems and apparatuses, not just the pulmonary one [4] . In non-severe forms of COVID-19, that can and must be managed and treated by avoiding the hospitalization of the patient, early recognition of symptoms is a fundamental prerequisite for immediate therapeutic management [5] . The so-called long COVID is the set of symptoms that accompanies the patient even for months after discharge from the hospital. These symptoms include easy muscle fatigue, moderate breathlessness, persistent headache, the feeling of a foggy head, and the development of psychiatric disorders [6] . In general, the quality of life of at least half of the patients who come out of the COVID-19 syndrome, both mild and severe, shows a markedly worsening despite having passed a difficult physical and psychological test [7] . The neurological impairment of post-COVID-19 can have different pathophysiological bases: direct neuro-invasion with a damage on the neuronal pathway, indirect effects mediated by hypoxia, hypertension, coagulopathy and cytokine storm on the CNS, up to the worsening of pre-existing brain diseases or new ones (cerebrovascular events, infectious and toxic encephalopathy, meningoencephalitis, Guillain Barré syndrome) [8] . Long-term complications arise from this multifaceted picture. Among all the neurological disorders that can most frequently be found in the "long COVID-19," it is not necessary to underestimate the persistent headache for at least 6 Internal Medicine Unit, Belcolle Hospital, Viterbo, Italy cognitive blunting, such as "brain fog," and as worsening/ chronicization of a pre-existing migraine [9] . Although headache does not represent a prognostic picture for the evolution of COVID-19, it must always be taken into consideration as a possible chronic sequela of the infection. A quite similar clinical picture of sub-continuous headache was already described, as a consequence of other viral infections, as the New Daily Persistent Headache (NDPH), and had been described by Diaz-Mitoma and Walter Vanast of McGill University in Montreal, as headache resulting from Esptein-Barr Virus infection and published in 1987 in Lancet [10] , headache syndrome lasting >3 months. However, this putative similarity between NDPH and long-COVID headache needs further discussion and data. In this scientific moment of a not yet incomplete consensus not only on the nosography classification of the sequelae of COVID-19, namely long-COVID, post-acute sequelae of SARS-COV-2 (PASC, COVID long haulers, etc.), the presence of this multifaceted neurological symptomatology, headache and foggy feeling, even after negativization by COVID-19 infection, must be taken into serious consideration in order to avoid a chronicization of the headache and a further worsening of the patient's quality of life [11] [12] [13] [14] [15] [16] [17] . Furthermore, deranged innate immune signaling and activation of inflammasomes implicated in both COVID-19 headache and migraine [18] could also play a role in long-COVID headache, as well as sleep difficulties associated with long-COVID symptoms also be a significant element determining cognitive problems, poor memory, and chronicity of headaches [19] . Author Contribution All the authors contributed equally to the preparations of the manuscript. Funding Open access funding provided by Università degli Studi di Roma La Sapienza within the CRUI-CARE Agreement. Data Availability Not applicable. Code Availability Not applicable. Ethics Approval Not applicable. Consent for Publication All the authors approved the final version of the manuscript. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. Headache as a prognostic factor for COVID-19 Characteristics and clinical features of SARS-CoV-2 infections among ambulatory and hospitalized children and adolescents in an integrated health care system in Tennessee. medRxiv Symptoms of COVID-19 outpatients in the United States COVID-19: is it just a lung disease? A case-based review Clinical management of adult coronavirus infection disease 2019 (COVID-19) positive in the setting of low and medium intensity of care: a short practical review 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records COVID-19 sequelae in adults aged less than 50 years: a systematic review COVID-19 and SARS-Cov-2 infection: pathophysiology and clinical effects on the nervous system Long-COVID: an evolving problem with an extensive impact Increased frequency of Epstein-Barr virus excretion in patients with new daily persistent headaches 2019-NCoV: What every neurologist should know? Defining post-COVID symptoms (post-acute COVID, long COVID, persistent post-COVID): an integrative classification Long COVID -an early perspective Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers Post-acute COVID-19 syndrome COVID symptoms, symptom clusters, and predictors for becoming a long-hauler: looking for clarity in the haze of the pandemic COVID-19 is a real headache! Headache 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations